BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10526698)

  • 1. Prevention of sudden cardiac death with beta blockers.
    Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of beta-blockers in preventing sudden death in heart failure.
    Teerlink JR; Massie BM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers for preventing sudden cardiac death.
    Giles TD; Basile JN
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta receptor blockade in preventing sudden death.
    Wikstrand J; Kendall M
    Eur Heart J; 1992 Sep; 13 Suppl D():111-20. PubMed ID: 1356781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug treatment for secondary prevention of myocardial infarction].
    Ishikawa K; Kanamasa K; Hayashi T; Takenaka T; Inoki T; Katayama K; Miyataka M; Kimura A; Yabushita H; Taniwa T; Ikeda A
    J Cardiol; 2000 Jun; 35(6):397-408. PubMed ID: 10884976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials.
    Cucherat M
    Eur Heart J; 2007 Dec; 28(24):3012-9. PubMed ID: 17981830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of sudden cardiac death.
    Goldberger JJ
    Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prevention of sudden cardiac death--what have we learnt from randomised clinical trials?
    Kam RM; Teo WS; Koh TH; Lim YL
    Singapore Med J; 1999 Nov; 40(11):707-10. PubMed ID: 10709412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-arrhythmic therapy of ventricular tachyarrhythmias and sudden cardiac death after acute myocardial infarction.
    Schweitzer P
    Vnitr Lek; 2006 Dec; 52(12):1185-9. PubMed ID: 17299912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
    Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
    Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with beta blockers in heart failure mortality trials.
    Eichhorn EJ
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V21-9. PubMed ID: 10526700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.